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a b s t r a c t
Recent work suggests that a dose of 200–400 mg caffeine can enhance both vigilance and the executive
control of visual attention in individuals with low caffeine consumption proﬁles. The present study seeks
to determine whether individuals with relatively high caffeine consumption proﬁles would show similar
advantages. To this end, we examined the effects of four caffeine doses (0 mg, 100 mg, 200 mg, 400 mg)
on low- and high-level visual attention in individuals with high consumption proﬁles (n = 36), in a double-blind study using a repeated measures design. Results from the Attention Network Test indicated that
caffeine enhanced both vigilance and the executive control of visual attention, but only at the highest
administered dose (400 mg). We demonstrate that in habitual consumers high doses of caffeine can produce beneﬁcial changes in visual attention. These results carry implications for the theorized interactions
between caffeine, adenosine and dopamine in brain regions mediating visual attention.
Published by Elsevier Inc.

1. Introduction
Caffeine (1,3,7-trimethylxanthine) is the most commonly consumed psychoactive stimulant in the world, and is often found to
enhance human vigilance and mental alertness (Lieberman,
2001; Nehlig, Daval, & Debry, 1992; Smith, 2002; Snel, Lorist, &
Tieges, 2004). For instance, individuals are able to sustain visual
vigilance for extended periods following caffeine consumption
(Frewer & Lader, 1991; Lieberman, Wurtman, Emde, Roberts, &
Coviella, 1987; Mitchell & Redman, 1992), and also show dosedependent performance improvements in accuracy and speeded
responses on simple and choice reaction time tasks (Kenemans &
Lorist, 1995; Lieberman, Tharion, Shukitt-Hale, Speckman, &
Tulley, 2002; Wesensten, Killgore, & Balkin, 2005). Caffeine has
also been implicated in the enhancement of certain higher-order
cognitive processes, such as those involved in the active monitoring and coordination of behavior. For instance, caffeine can reduce
response time costs during task switching (Tieges, Snel, Kok, Plat, &
Ridderinkhof, 2007; Tieges et al., 2006), enhance response inhibition (Barry et al., 2007), and reduce interference costs during the
Stroop color–word, ﬂanker, and other selective visual attention
tasks (Brunyé, Mahoney, Lieberman, & Taylor, 2010; Kenemans,
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Weileman, Zeegers, & Verbaten, 1999; Lorist, Snel, Kok, & Mulder,
1996). The effects of caffeine on such higher-order tasks, however,
are somewhat equivocal; indeed some other recent work suggests
that caffeine does not affect selective visual attention (Kenemans &
Verbaten, 1998; Lorist & Snel, 1997) or response inhibition (Tieges,
Snel, Kok, & Ridderinkhof, 2009).
There are many methodological differences between these
studies that may account for the discrepant ﬁndings. First, studies
ﬁnding no effect of caffeine on higher-order tasks (e.g., Kenemans
& Verbaten, 1998; Lorist & Snel, 1997; Tieges et al., 2009) typically
use a 3 mg/kg dose (approx. 200 mg) of caffeine in individuals with
high caffeine consumption proﬁles. However, the effective dosage
to elicit changes in higher-order cognitive processes may be greater in individuals who habitually consume 2–4 cups of coffee (170–
340 mg caffeine) per day (Juliano & Grifﬁths, 2004; Kenemans
et al., 1999). Indeed chronic caffeine consumption increases the
number of adenosine receptors in the brain, suggesting that higher
caffeine doses may be necessary to achieve substantial dopamine
increases in high consumers (Daval, von Lubitz, Deckert, Redmond,
& Marangos, 1989; Fastbom, Post, & Fredholm, 1990; Varani et al.,
1999). Second, caffeine effects tend to be greatest on highly practiced tasks (Loke, 1992), and thus some null effects may be partially attributed to the lack of a substantial practice session
(Kenemans & Verbaten, 1998; Lorist & Snel, 1997). The present
study accounts for these methodological issues in two ways. First,
we use a more comprehensive dose–response design with four
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levels of caffeine (0 mg, 100 mg, 200 mg, 400 mg) in participants
with high caffeine consumption proﬁles (i.e., P500 mg per day);
we hypothesize that 200 mg may not be sufﬁcient to modulate
higher-order cognitive processes related to the control of visual
attention (Tieges et al., 2009), but a 400 mg dose may produce signiﬁcant effects. Our design allows a test of this hypothesis. Second,
we provide participants with multiple practice sessions to increase
task familiarity and reduce training effects across sessions.
With this improved design, there are several reasons to expect
caffeine to modulate higher-order cognitive processes, particularly
the effortful control of visual attention. Studies have demonstrated
that caffeine reduces response conﬂicts in the classic Stroop color–
word task (Hasenfratz & Battig, 1992; Kenemans et al., 1999).
Further, meta-analyses of Stroop-related brain activation have detailed a network of brain areas, including the anterior cingulate
cortex (ACC), as responsible for successful control of visual attention (Bush, Luu, & Posner, 2000; Bush et al., 1998). In fact, many
studies have identiﬁed the ACC’s critical importance for successful
control of visual attention across a variety of tasks (Botvinick,
Braver, Barch, Carter, & Cohen, 2001; Casey et al., 2000; Fan,
Flombaum, McCandliss, Thomas, & Posner, 2003; Mac Donald,
Cohen, Stenger, & Carter, 2000). The ACC receives one of the highest levels of dopaminergic innervation in the brain (Lumme, Aalto,
Ilonen, Någren, & Hietala, 2007), and caffeine is a highly reliable
catalyst for dopaminergic availability through its antagonistic
effects on adenosine (Garrett & Grifﬁths, 1997; Popoli, Reggio,
Pezzola, Fuxe, & Ferré, 1998; Solinas et al., 2002). In support of this
position, there is recent neuroimaging evidence demonstrating
that the ACC is reliably up-regulated by caffeine consumption
(Koppelstaetter et al., 2008). Given these relationships between
caffeine, adenosine, dopamine, the ACC and executive function,
we expect that high doses of caffeine may enhance the effortful
control of visual attention.

2. The present study
Given the high and increasing prevalence of caffeine consumption (Malinauskas, Aeby, Overton, Carpenter-Aeby, & BarberHeidal, 2007; Reissig, Strain, & Grifﬁths, 2009), it is critical to
understand how the growing population of habitual consumers
might show modulation of executive control as a function of acute
caffeine consumption. Indeed earlier results with relatively low
frequency consumers may not be generalizable to samples with
consumption proﬁles that better reﬂect caffeine’s prevalence. To
this end, the present study assessed how four doses of our Treatment variable (0 mg, 100 mg, 200 mg, 400 mg caffeine) would affect habitual consumers’ performance on the Attention Network
Test (ANT; Fan, McCandliss, Sommer, Raz, & Posner, 2002). The
ANT is a composite task that reliably tests the independent functioning of three theorized (Posner, 1990) visual attention networks: alerting, orienting, and executive control (Fan et al., 2002,
2003; Neuhaus et al., 2007; Posner & Rothbart, 2005).
Alerting involves achieving and maintaining a state of alertness
(vigilance) during task performance; the ANT tests the functioning
of this network by assessing the utility of predictive cues regarding
trial onset. Neuroimaging studies demonstrate that alerting cues
activate the thalamus and bilateral frontal and parietal brain
regions (Fan, McCandliss, Fossella, Flombaum, & Posner, 2005;
Marrocco & Davidson, 1998); given that the thalamus and prefrontal cortex receive dense dopaminergic innervation (SánchezGonzález, García-Cabezas, Rico, & Cavada, 2005; Williams &
Goldman-Rakic, 1995), we expected that alerting would be improved as a function of caffeine dose. This hypothesis is in line with
studies demonstrating improvement in basic psychomotor speed
and vigilance performance in a positive dose–response relationship
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with caffeine consumption (for reviews, see Koelega, 1993;
Lieberman, 1992, 2001; Smith, 2002; Snel et al., 2004; Spiller,
1997).
Orienting involves selectively attending to cued regions of space
in anticipation of stimulus onset; the ANT tests the functioning of
this network by assessing the utility of predictive relative to
non-predictive spatial cues regarding an upcoming trial location.
Neuroimaging studies demonstrate that orienting involves the
activation of the superior parietal lobe (Corbetta, Kincade, Ollinger,
McAvoy, & Shulman, 2000; Fan et al., 2005). Given sparse dopaminergic innervations of the parietal lobes (Lidow, Goldman-Rakic,
Rakic, & Innis, 1989; Tassin et al., 1978), and recent work demonstrating only marginal effects of caffeine on orienting function in
low caffeine consumers (Brunyé et al., 2010), we expected that caffeine consumption would not affect orienting function in a sample
of habitual consumers.
The executive control of visual attention involves the resolution
of conﬂicts between potential responses to a presented stimulus;
the ANT tests the functioning of this network by assessing response
time decrements produced as a function of response-incongruent
information ﬂanking a target stimulus. Neuroimaging studies demonstrate that this type of visual executive control process activates
the anterior cingulate cortex (ACC) and lateral prefrontal cortices
(Botvinick et al., 2001; Bush et al., 2000; Casey et al., 2000; Fan
et al., 2005). Given recent work demonstrating improvement in visual executive control in low consumers (Brunyé et al., 2010),
dense dopaminergic innervations in the ACC and prefrontal brain
regions (Lumme et al., 2007), and the fact that dopamine binding
in the ACC moderates executive function (Ko et al., 2009), we expected that a high dose (e.g., 400 mg) of caffeine would produce
similar effects in individuals with high consumption proﬁles.
For both alerting and executive control, a competing hypothesis
is offered by research demonstrating increased adenosine receptor
densities in the habitual consumer brain (Daval et al., 1989;
Fastbom et al., 1990; Varani et al., 1999), which may limit the
dopaminergic response to our range of caffeine doses. If this is
the case, then results will not demonstrate modulation of executive control as a function of caffeine dosage.

3. Method
3.1. Participants
Thirty-six high caffeine consuming (M = 592.3 mg/day) undergraduate students (10 male; mean age 20.11; mean BMI 23.06)
participated for monetary compensation ($10 USD/h). All participants were non-nicotine users, in good health, and did not use prescription medication other than oral contraceptives. Written
informed consent was obtained, and all procedures were jointly
approved by the Tufts University Institutional Review Board and
the Human Use Review Committee of the US Army Research Institute for Environmental Medicine.

3.2. Design
We used a within-participants design with four levels of a double-blind independent variable, Treatment (0 mg, 100 mg, 200 mg,
400 mg caffeine). The 400 mg dose was chosen given that 20 oz
coffees sold at major franchise coffee houses typically contain from
350 to 450 mg caffeine (McCusker, Goldberger, & Cone, 2003). Caffeine (99.8% pure anhydrous USP-grade powder) and placebo
(physiologically inert microcrystalline cellulose powder) were
administered in identical capsule form with water, and Treatment
order was counterbalanced across participants in a Latin square.
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3.3. Materials
3.3.1. Manipulation check
To assess the effectiveness of caffeine in modulating participant
affective arousal, we administered the Brief Mood Introspection
Scale (BMIS; Mayer & Gaschke, 1988) both pre-caffeine and postmetabolism. This scale involves rating a series of 16 affective adjectives (e.g., peppy, tired, active, calm) on scales that range from 1
(deﬁnitely do not feel) to 4 (deﬁnitely feel).
3.3.2. Attention Network Test
The ANT involves responding to the direction of a central arrow
that faces either left or right. On some trials the presentation of the
arrow is preceded by cues that alert participants to the onset of a
trial, and on some trials participants also receive a cue that orients
them to a particular region of the screen (above or below ﬁxation).
The central arrow appears with two ﬂanking stimuli on either side,
either in the form of neutral lines or arrows facing either a congruent or incongruent direction relative to the central arrow. Accuracy
and response time are measured when the participant responds to
the facing direction of the central arrow. Alerting is measured as
the extent to which a cue can alert the participant to trial onset,
relative to when no cue is provided. Orienting is measured as the
extent to which a spatially-determinate cue can orient a participant to the appropriate screen region where the central arrow will
appear (above or below ﬁxation) relative to when a spatiallyindeterminate cue is provided. Executive control is measured as
the extent to which incongruent ﬂanking arrows interfere with a
participant’s response relative to when ﬂanking arrows are congruent with the facing direction of the central arrow. The ANT involves
three blocks of 96 trials each, presented in random order; for a
more complete task description refer to Fan et al. (2002). Participants are instructed to respond to the facing direction of the central arrow as quickly and accurately as possible; they are also
told that on certain trials they would receive cues that indicate
when the trial was about to begin (alerting) and/or where it would
appear on the screen (orienting).
3.4. Procedure
Participants visited the laboratory on ﬁve separate sessions,
each separated by at least 3 days: one normal consumption session
and four test sessions. All sessions took place in the morning at a
consistent time within participants. During the normal consumption session, participants practiced a full version of the ANT and
completed all tasks in the same order as during the test sessions;
for this session only, participants were instructed to consume their
normal amounts of caffeine prior to coming to the laboratory, and
did not consume a capsule. The four subsequent test sessions followed a 12-h water-only fast wherein participants were instructed
not to consume any substance other than water; note that a 12-h
fast is a sufﬁcient wash-out period for caffeine given research demonstrating mean plasma and elimination half-lives of 2.5–5 h in
healthy participants (Arnaud, 1987; Culm-Merdek, von Moltke,
Harmatz, & Greenblatt, 2005; IOM, 2001; Statland & Demas,
1980). Participants were instructed not to use any over-thecounter medications or herbal supplements for 24 h prior to testing; to encourage compliance with these instructions we collected
saliva samples upon arrival for each test session (not further analyzed herein; see also Brunyé et al., 2010; Tieges et al., 2009).
During each test session, participants completed the BMIS upon
arrival, provided a saliva sample, consumed their assigned Treatment capsule along with a cup of water, and took a 20-min break
(to allow for sufﬁcient plasma concentrations of caffeine; Arnaud,
1987). They then completed a 3-min practice session of the ANT,

performed the full ANT (approximately 15 min), and then again
completed the BMIS.
4. Results
Two participants were removed from further analysis for not
completing the ANT during one or more test sessions.
4.1. Self-reported mood state
We performed a repeated-measures ANOVA on adjective ratings following caffeine consumption. As detailed in Table 1, we
conﬁrmed the effectiveness of our Treatment manipulation, with
signiﬁcant increases in participants’ ratings of how Lively, Jittery,
Peppy, Nervous and Active they felt as a function of Treatment level;
conversely, there were signiﬁcant decreases in ratings of Tired,
Drowsy, and Calm. Table 1 lists Dunnett’s test (comparing each
dose to the 0 mg condition) results for adjectives with signiﬁcant
ANOVA effects.
4.2. Attention Network Test
4.2.1. Treatment effects on Attention Networks
To evaluate the effect of caffeine on ANT performance, we calculated difference scores (i.e., Fan et al., 2002, 2005; Redick & Engle,
2006) to independently assess the functioning of each attention
network: alerting, orienting, and executive control. Alerting difference scores were calculated by subtracting mean RTs during trials
with double-cue conﬁguration from mean RTs from trials with no
cues (higher scores indicate more efﬁcient alerting function). Orienting difference scores were calculated by subtracting mean RTs
during spatial cue trials (top versus bottom cue) from trials with
a center cue only (higher scores indicate more efﬁcient orienting
function). Finally, executive control scores were calculated by subtracting mean RTs during congruent ﬂanker trials (i.e., ﬂanking arrows matching facing direction of central arrow) from trials with
incongruent ﬂankers (i.e., ﬂanking arrows mismatching facing
direction of central arrow); lower executive control difference
scores indicate more efﬁcient executive control function. Fig. 1 depicts each of these three difference scores as a function of caffeine
Treatment levels.
For all analyses, effect sizes are denoted using Cohen’s d and
eta-squared (g2). To analyze difference scores as a function of

Table 1
BMIS adjective ratings as a function of Treatment dosage.
Adjective

Treatment
0 mg

Lively
Happy
Sad
Tired
Caring
Content
Gloomy
Jittery
Drowsy
Grouchy
Peppy
Nervous
Calm
Loving
Fed Up
Active
*

100 mg

200 mg

400 mg

M

SD

M

SD

M

SD

M

SD

2.29
2.85
1.82
3.14
2.62
2.85
1.76
1.82
2.79
1.82
2.00
1.97
3.03
2.56
2.11
2.26

.68
.61
.52
.56
.69
.66
.69
.72
.73
.76
.74
.72
.63
.61
.91
.67

2.62
2.94
1.74
2.74*
2.68
3.03
1.73
1.74
2.44
1.82
2.18
1.79
3.00
2.56
1.94
2.53*

.60
.69
.57
.89
.77
.72
.67
.67
.93
.63
.79
.64
.63
.79
.81
.71

2.82*
2.76
1.71
2.65*
2.79
2.88
1.97
1.94
2.35*
1.88
2.09
2.00
2.91
2.56
1.91
2.41

.63
.69
.63
.88
.69
.73
.83
.81
.77
.81
.87
.85
.71
.75
.71
.70

2.74*
2.82
1.71
2.76*
2.68
2.88
1.79
2.29*
2.26*
1.85
2.47*
2.26
2.65*
2.59
1.88
2.56*

.83
.72
.58
1.05
.64
.59
.77
.91
1.08
.78
.86
.86
.77
.82
.77
.70

Signiﬁcant Dunnett’s test results, comparing Treatment level to 0 mg placebo.
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(Tieges et al., 2009), but a 400 mg dose produced signiﬁcant effects.
We speciﬁcally detail our results and discuss implications below as a
function of the three attention networks under examination: alerting, orienting, and executive control.
5.1. Alerting

Fig. 1. Mean difference scores and standard errors for each of the three attention
networks and four Treatment levels. Note that higher difference scores in the
alerting and orienting networks indicate greater performance; conversely, lower
difference scores in the executive control network indicate greater performance.
N.C. = normal consumption.

Treatment (0 mg, 100 mg, 200 mg, 400 mg caffeine), we conducted
three separate single-factor repeated-measures ANOVAs, one for
each attention network. Analysis of alerting difference scores demonstrated a marginal effect of Treatment, F(3, 99) = 2.19, p = .09,
g2 = .06. Comparisons using the Dunnett’s test (comparing each
dose to the 0 mg condition) revealed higher alerting difference
scores in the 400 mg condition, td(33) = 2.56, p < .05, d = .36 (all
other p’s > .05). Analysis of orienting difference scores did not reveal an effect of Treatment, F(3, 99) = .60, p > .05, g2 = .02. Finally,
analysis of executive control difference scores revealed an effect
of Treatment, F(3, 99) = 3.75, p < .05, g2 = .10; comparisons using
the Dunnett’s test revealed lower difference scores in the 400 mg
condition, td(33) = 3.17, p < .01, d = .60 (all other p’s > .05).
4.2.2. Testing for withdrawal effects
To rule out the possibility that our results could be solely attributed to performance reduction on the 0 mg day (due to withdrawal),
we conducted three t-tests comparing the normal consumption day
to the 0 mg day (one for each attention network difference score).
Though withdrawal led to numerically poorer performance for all
three attention networks at the 0 mg dose relative to the normal
consumption day (cf., Lane & Phillips-Bute, 1998), no analysis of
those differences reached statistical signiﬁcance: alerting scores,
t(33) = 1.39, p > .05, orienting scores, t(33) = .65, p > .05, and executive control scores, t(33) = 1.16, p > .05. The lack of signiﬁcant withdrawal effects is likely due to average consumption rates being
inﬂuenced by consumption throughout the day, whereas all laboratory sessions occurred in the morning (cf., Fredholm, Bättig, Holmén,
Nehlig, & Zvartau, 1999).
5. Discussion
The present study extended previous work examining caffeine effects on lower- and higher-level visual attention by using a more
comprehensive dose–response design, an integrated and reliable
attention task, and an extended practice session. Whereas we cannot
be certain that the exclusion of a practice session would negate our
effects, our dose–response design did allow for a direct comparison
of a commonly used dose (200 mg) with a substantially higher dose
(400 mg) in a sample of high consumers. As hypothesized, 200 mg
was not sufﬁcient to modulate lower- or higher- order cognitive
processes related to the deployment and control of visual attention

The alerting network is theorized to be responsible for achieving and maintaining vigilance and alertness during the performance of continuous task (Fan et al., 2002; Posner, 1990, 2004).
Functional neuroimaging studies demonstrate that successful
alerting recruits the prefrontal cortex and thalamus (Fan et al.,
2005), two brain areas that receive dense dopaminergic innervations. In fact, the thalamus is one of the few brain areas with colocated adenosine (A2A) and dopamine (D2) receptors (i.e., Fink
et al., 1992). Given that caffeine reliably up-regulates dopaminergic availability through its inhibitory effects on adenosine, we
expected that a high dose of caffeine would improve alerting performance in high consumers; our results partially support this
hypothesis. Alerting difference scores showed overall increases as
a function of caffeine dose, though only at the 400 mg dose did
the increase become signiﬁcant relative to placebo. Presently, it
could be the case that high habitual caffeine consumption levels
may increase requisite doses to achieve substantial alerting effects;
in fact, our earlier work examining the ANT found effects of caffeine on alerting functioning at both 200 mg and 400 mg when
examining non-habitual caffeine consumers (Brunyé et al., 2010).
Overall, the results from both habitual and non-habitual consumers support a large body of literature demonstrating caffeine’s positive inﬂuence on lower-level visual attention and psychomotor
tasks (Frewer & Lader, 1991; Kenemans & Lorist, 1995; Lieberman
et al., 1987, 2002; Mitchell & Redman, 1992; Wesensten et al.,
2005), but underscore the importance of examining these effects
in a range of participant consumption proﬁles.
5.2. Orienting
The orienting network allows individuals to use cues to selectively orient attention to particular regions of space in preparation
for an upcoming stimulus. Functional neuroimaging studies demonstrate that the orienting network is primarily the locus of the
superior parietal lobe (i.e., Corbetta et al., 2000; Fan et al., 2005),
a brain area thought to have relatively low dopamine innervation
in humans and other animals (Lidow et al., 1989; Tassin et al.,
1978). Given that the behaviorally signiﬁcant effects of caffeine
on the central nervous system are thought to result primarily from
its direct effects on adenosine (at A1 and A2A receptors) and indirect effects on dopaminergic availability (Cropley, Fujita, Innis, &
Nathan, 2006; Fredholm, 1980, 1995; Varani et al., 1999), we expected that caffeine would not affect orienting function. Our results support this hypothesis, providing no evidence that caffeine
affects orienting function, somewhat in line with recent results
found with low consumers (Brunyé et al., 2010). In this earlier research, we identiﬁed marginal effects of caffeine on orienting system functioning (at 400 mg); we propose that caffeine has only
minor effects on the orienting of attention, and that these effects
only occur at high doses in participant samples with low consumption proﬁles. Further, these results support the notion that caffeine-induced changes in cognitive performance may be related
more to its effects on dopaminergic rather than noradrenergic systems (i.e., Fredholm et al., 1999; Garrett & Grifﬁths, 1997; Lorist &
Tops, 2003; Nehlig, 1999; Tieges, Ridderinkhof, Snel, & Kok, 2004);
indeed whereas the parietal lobes are not densely innervated by
dopamine, they are a fundamental component of the brain’s
norepinephrine system (Coull, Frith, Frackowiak, & Grasby, 1996;
Marrocco, Witte, & Davidson, 1994). If the noradrenergic effects
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of caffeine (via adenosine) affect visual attention, then one might
expect to see such an effect during the orienting of attention.

5.3. Executive control network
The executive control network allows individuals to reduce the
performance degradation typically seen with action-incompatible
visual information (i.e., incongruent relative to congruent or neutral ﬂanker arrows; Posner, 1990, 2004). Functional neuroimaging
studies have demonstrated that the executive control of visual
attention recruits both the anterior cingulate and prefrontal cortex
(Botvinick et al., 2001; Bush et al., 1998, 2000; Casey et al., 2000;
Fan et al., 2003; Mac Donald, Cohen, Stenger, & Carter, 2000). Given
that these areas are typically up-regulated by caffeine consumption (Koppelstaetter et al., 2008), and executive function in these
areas is thought to be supported by dopaminergic availability
(Ko et al., 2009), we expected that a high dose of caffeine would enhance the executive control of visual attention. Congruent with recent ﬁndings examining ANT performance in low consumers
(Brunyé et al., 2010), we identiﬁed dose-dependent increases in
the ability to inhibit action-incompatible information; this effect
only reached signiﬁcance at a dose exceeding that used in prior
studies (i.e., 400 mg). As a reminder, lower executive control difference scores indicate higher functioning (see Fig. 1). Our ﬁndings
highlight the importance of examining a broad range of doses
when examining habitual high consumer populations. Due at least
to higher adenosine receptor density in habitual caffeine consumers (Daval et al., 1989; Fastbom et al., 1990; Varani et al., 1999),
higher doses may be required to elicit substantial effects of caffeine
on adenosine inhibition and dopamine availability.
The present effect on executive control also may speak to the
distinction between reactive and active inhibition (Fillmore &
Rush, 2002). Active inhibition involves actively and deliberately
inhibiting thoughts and actions, such as immediately aborting a
learned response (i.e., stop-signal task; Logan & Cowan, 1984), or
switching task sets (i.e., Monsell, 2003). In contrast, reactive inhibition involves interference control mechanisms during a relatively
automated process (i.e., De Jong, Liang, & Lauber, 1994), such as
inhibiting an inappropriate response when a ﬂanking stimulus
mismatches a target stimulus (i.e., incongruent versus congruent
ﬂanker trials). Though our design does not speciﬁcally allow for a
dissociation of active and reactive inhibition, our ﬁndings support
a growing consensus that caffeine may enhance reactive inhibition
(Hasenfratz & Battig, 1992; Kenemans et al., 1999; Lorist, Snel, Kok,
& Mulder, 1994; Lorist et al., 1996), unlike results found with active inhibition (e.g., Barry et al., 2007; Tieges et al., 2009). Some recent evidence suggests that active inhibition may bypass the
striatum (Aron & Poldrack, 2006), which holds one of the highest
adenosine receptor densities in the brain (Fredholm et al., 1999)
and is thought to be of greater importance for reactive relative to
active inhibition (Cropley et al., 2006).

6. Conclusions
The present study identiﬁed effects of caffeine on performance
during a modiﬁed ﬂanker task designed to measure the relative
function of the alerting, orienting and executive control networks.
In general, caffeine improves the efﬁciency with which participants
can take advantage of cues that alert them to trial onset, and
further improves their ability to efﬁciently inhibit the inﬂuence
of action-incompatible stimuli. In the present high consumer participant sample, these effects only occurred at the highest caffeine
dose (400 mg) and did not appear to be attributable to withdrawal
effects.

The effect on alerting supports several decades of research demonstrating the positive effects of caffeine on tasks requiring
speeded responses and continuous vigilance (e.g., Fine et al.,
1994; Kenemans & Lorist, 1995; Lieberman et al., 2002; Wesensten
et al., 2005). Caffeine’s effects on such lower-level attention tasks
are likely due to its antagonistic role at adenosine A1 and A2A
receptors in areas with high concentrations of dopaminergic innervation; the up-regulation of dopamine in frontal and thalamic
brain regions is thought to result in increased feelings of wakefulness and pronounced motor activity, ultimately improving performance on tasks requiring speeded responses (i.e., Garrett &
Grifﬁths, 1997; Popoli et al., 1998; Solinas et al., 2002). A high dose
of caffeine also improved the executive control of visual attention,
supporting recent work with non-habitual caffeine consumers
(Brunyé et al., 2010), and demonstrating caffeine’s positive effects
on tasks requiring reactive inhibition. These effects are likely
attributed to dopamine effects on brain areas responsible for successful inhibitory control of attention, such as the anterior cingulate, striatum, and prefrontal cortex (Coull et al., 1996; Cropley
et al., 2006; Fan et al., 2005; Ferre, Fredholm, Morelli, Popoli, &
Fuxe, 1997; Fredholm et al., 1999; García-Cabezas, Rico, SánchezGonzález, & Cavada, 2007; Sawaguchi & Goldman-Rakic, 1991,
1994; Smits et al., 1987; Sánchez-González et al., 2005; Williams
& Goldman-Rakic, 1995).
Caffeine is the most popular and widely-consumed psychoactive stimulant in the world, and carries diverse implications for
central nervous system function. Its prevalence underscores the
importance of understanding the breadth of its effects at a range
of doses in both high- and low-consumers. We add to a growing
body of evidence suggesting that caffeine can have varied and substantial effects on the deployment and control of visual attention.
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